Skip to content
Clinical Trials – Menter Dermatology Research Institute Logo Clinical Trials – Menter Dermatology Research Institute Logo Clinical Trials – Menter Dermatology Research Institute Logo
  • HOME
  • ABOUT
    • ABOUT MDRI
    • INFORMATION FOR SPONSORS
    • PATIENT PERSPECTIVES
  • MEET THE TEAM
  • OUR STUDIES
    • RECRUITING STUDIES
    • OTHER ACTIVE STUDIES
  • NEWS & RESOURCES
    • MDRI NEWS
    • RESOURCES
    • MDRI BLOG
    • FAQs
  • REGISTER FOR A TRIAL
  • HOME
  • ABOUT
    • ABOUT MDRI
    • INFORMATION FOR SPONSORS
    • PATIENT PERSPECTIVES
  • MEET THE TEAM
  • OUR STUDIES
    • RECRUITING STUDIES
    • OTHER ACTIVE STUDIES
  • NEWS & RESOURCES
    • MDRI NEWS
    • RESOURCES
    • MDRI BLOG
    • FAQs
  • REGISTER FOR A TRIAL
  • HOME
  • ABOUT
    • ABOUT MDRI
    • INFORMATION FOR SPONSORS
    • PATIENT PERSPECTIVES
  • MEET THE TEAM
  • OUR STUDIES
    • RECRUITING STUDIES
    • OTHER ACTIVE STUDIES
  • NEWS & RESOURCES
    • MDRI NEWS
    • RESOURCES
    • MDRI BLOG
    • FAQs
  • REGISTER FOR A TRIAL

Dermatologic Therapy IXE

Home/Ixekizumab in the treatment of moderate-to-severe psoriasis: Patient Adherence, Preferences and Satisfaction Summary/Dermatologic Therapy IXE
Previous
Dermatologic Therapy IXE

adminmderm2021-07-20T20:12:29+00:00

MDRI BLOG CATEGORIES

  • COVID-19 Related
  • MDRI Clinical Trials
  • Published Work
  • Psoriasis
  • Pemphigus
  • Palmoplantar Pustulosis
  • Hidradenitis Suppurativa (HS)
  • Atopic Dermatitis (Eczema)
  • Videos & Podcasts
  • Dr. Alan Menter
  • Archive

Register for a Trial
Full Dermatology Services Offered at Texas Dermatology Associates

CONTACT INFORMATION

Menter Dermatology Research Institute
Baylor Medical Pavilion
3900 Junius St, #125
Dallas, TX 75246

 855-554-6374

Map & Directions

Map & Directions
© Copyright    |  Menter Dermatology Research Institute   |   All Rights Reserved   |   Powered by Gatorwebs Creative
Page load link